PUBLISHER: Grand View Research | PRODUCT CODE: 1609577
PUBLISHER: Grand View Research | PRODUCT CODE: 1609577
The global blood collection market size is estimated to reach USD 6.71 billion by 2030, expanding at a CAGR of 8.72% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising incidence of infectious and non-communicable diseases is a major factor anticipated to propel the market growth during the forecast period. Moreover, the global burden of chronic diseases is rising rapidly. Cardiovascular disease (CVD) accounts for nearly half of all chronic disease deaths. According to the American Heart Association, the incidence of CVD in the U.S. is estimated to rise from 36.9 % (2010) to 38.7 % (2020) and 40.5% by 2030.The COVID-19 pandemic had a significant impact on the market, encompassing both direct and indirect effects. Initially, the consumption of blood collection devices for conventional diseases was reduced due to the disruption caused by the pandemic and the strain on healthcare resources.
However, as it became apparent that other diseases could be life-threatening risks for individuals infected with COVID-19, there was an increased emphasis on routine checks for blood-related diseases. This led to a temporary surge in sales in the market, which eventually led the market gradually return to its projected growth rate in 2022.The growing rate of novel product launches and investments is anticipated to fuel market growth during the forecast period. For instance, in May 2022, Terumo Blood and Cell Technologies announced the opening of its new production plant in Colorado. The plant will cater to customers in the source plasma collections by providing single-use collection kits for the newly FDA-approved Rika Plasma Donation System. This will ensure a reliable supply of collection sets specifically designed for the Rika system.